Evidence map›Paper›PMID 41596139›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Pain Hypersensitivity in a Mouse Model of Marfan Syndrome.

Rebecca Kordikowski, Joana Coutinho, Ignacio Martínez-Martel, Clara Penas, Beatriz Martín-Mur, Belén Pérez, Francesc Jiménez-Altayó, Olga Pol

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca KordikowskiGrup de Neurofarmacologia Molecular, Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0009-0006-1085-9478
Joana CoutinhoInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0009-0009-2097-7883
Ignacio Martínez-MartelGrup de Neurofarmacologia Molecular, Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0009-0006-3100-8293
Clara PenasInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0000-0003-0554-3832
Beatriz Martín-MurCentro Nacional de Análisis Genómico (CNAG), Universitat de Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-6006-3295
Belén PérezInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0000-0001-5801-1704
Francesc Jiménez-AltayóInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0000-0002-9034-2041
Olga PolGrup de Neurofarmacologia Molecular, Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0002-4621-8457

Funding

Generalitat de Catalunya 2021 SGR 00548Generalitat de Catalunya 2021 SGR 00969Ministerio de Ciencia e Innovación and Agencia Estatal de Investigación of Spain PID2020-113634RB-C22/AEI/10.13039/501100011033Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (FEDER), Unión Europea PI21/00592
6 · The paper itself

Abstract

Marfan syndrome (MFS) is a genetic disorder caused by mutations in the fibrillin-1 (Fbn1) gene, leading to structurally abnormal elastic fibers and diverse clinical manifestations. Aortic root dilation represents the most serious threat, often requiring prophylactic surgical repair. Emerging evidence suggests that MFS patients experience increased pain sensitivity, contributing to functional impairment and reduced quality of life. Here, we used C57BL/6 wild-type and Fbn1

Indexed as

Marfan syndromemuscular deficitsneuroinflammationoxidative stresspainthoracic aorta aneurysm

Identifiers

PMID41596139
PMCPMC12837253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.